| Ident. | Authors (with country if any) | Title |
|---|
| 002E26 |
Gianluca Severi [Australie] ; Vanessa M. Hayes [Australie] ; Andrea A. Tesoriero [Australie] ; Melissa C. Southey [Australie] ; Hoa N. Hoang [Australie] ; Emma J. D. Padilla [Australie] ; Howard A. Morris [Australie] ; Dallas R. English [Australie] ; Robert L. Sutherland [Australie] ; Peter Boyle [France] ; John L. Hopper [Australie] ; Graham G. Giles [Australie] | The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels |
| 003580 |
Gianluca Seven [Australie] ; Vanessa M. Hayes [Australie] ; Emma J. D. Padilla [Australie] ; Dallas R. English [Australie] ; Melissa C. Southey [Australie, France] ; Robert L. Sutherland [Australie] ; John L. Hopper [Australie] ; Graham G. Giles [Australie] | The common variant rs1447295 on chromosome 8q24 and prostate cancer risk : Results from an Australian population-based case-control study |
| 003B08 |
Vanessa M. Hayes [Australie] ; Gianluca Severi [Australie] ; Emma J. D. Padilla [Australie] ; Howard A. Morris [Australie] ; Wayne D. Tilley [Australie] ; Melissa C. Southey [Australie, France] ; Dallas R. English [Australie] ; Robert L. Sutherland [Australie] ; John L. Hopper [Australie] ; Peter Boyle [France] ; Graham G. Giles [Australie] | 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia |
| 003B32 |
Catriona M. Mcneil [Australie] ; C. Marcelo Sergio [Australie] ; Luke R. Anderson [Australie] ; Claire K. Inman [Australie] ; Sarah A. Eggleton [Australie] ; Niamh C. Murphy [Australie] ; Ewan K. A. Millar [Australie] ; Paul Crea [Australie] ; James G. Kench [Australie] ; M. Chehani Alles [Australie] ; Margaret Gardiner-Garden [Australie] ; Christopher J. Ormandy [Australie] ; Alison J. Butt [Australie] ; Susan M. Henshall [Australie] ; Elizabeth A. Musgrove [Australie] ; Robert L. Sutherland [Australie] | c-Myc overexpression and endocrine resistance in breast cancer |
| 003B56 |
Gianluca Severi [Australie] ; Vanessa M. Hayes [Australie] ; Petra Neufing [Australie] ; Emma J. D. Padilla [Australie] ; Wayne D. Tilley [Australie] ; Sarah A. Eggleton [Australie] ; Howard A. Morris [Australie] ; Dallas R. English [Australie] ; Melissa C. Southey [Australie, France] ; John L. Hopper [Australie] ; Robert L. Sutherland [Australie] ; Peter Boyle [France] ; Graham G. Giles [Australie] | Variants in the Prostate-Specific Antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA |
| 003E95 |
Vanessa M. Hayes [Australie] ; Gianluca Severi [Australie] ; Melissa C. Southey [Australie, France] ; Emma J. D. Padilla [Australie] ; Dallas R. English [Australie] ; John L. Hopper [Australie] ; Graham G. Giles [Australie] ; Robert L. Sutherland [Australie] | Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival |
| 004D37 |
Jason S. Carroll [Australie] ; Danielle K. Lynch [Australie] ; Alexander Swarbrick [Australie] ; Jack-Michel Renoir [France] ; Boris Sarcevic [Australie] ; Roger J. Daly [Australie] ; Elizabeth A. Musgrove [Australie] ; Robert L. Sutherland [Australie] | p27Kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells |
| 005021 |
Sophie F. Doisneau-Sixou [France, Australie] ; Philippe Cestac [France] ; Sarah Chouini [France] ; Jason S. Carroll [France, Australie] ; Andrew D. Hamilton [États-Unis] ; Said M. Sebti [États-Unis] ; Marc Poirot [France] ; Patrick Balaguer [France] ; Jean-Charles Faye [France] ; Robert L. Sutherland [Australie] ; Gilles Favre [France] | Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells |
